Skip to main content

Closed

SUPN: Supernus Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Drug Manufacturers - Specialty & Generic

52W Range

40thpctl

Volume

0.75×avg

Market Cap

2.59BUSD

P/E Ratio

-87.3TTM

Div Yield

-ann

Supernus Pharmaceuticals, Inc.

SUPNNASDAQ Global Market·USD·Closed

Supernus Pharmaceuticals, Inc.

SUPNNASDAQ·USD·Closed

$44.63

−2.15%

$44.63

−$0.98 (2.15%)

52W Range

40thpctl

Volume

0.75×avg

Mkt Cap

2.59BUSD

P/E

-87.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings